p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical ProteinsAna Montero‐Calle, Rodrigo Barderas, José M. Pingarrón et al.|Cancers|2023Cited by 23
Seroreactivity Against Tyrosine Phosphatase PTPRN Links Type 2 Diabetes and Colorectal Cancer and Identifies a Potential Diagnostic and Therapeutic TargetMaría Garranzo‐Asensio, Rodrigo Barderas|Diabetes|2022Cited by 14